News Home

Is Selecta Biosciences Inc (SELB) Stock at the Top of the Biotechnology Industry?

Wednesday, October 05, 2022 03:04 PM | InvestorsObserver Analysts
Is Selecta Biosciences Inc (SELB) Stock at the Top of the Biotechnology Industry?

Selecta Biosciences Inc (SELB) is near the top in its industry group according to InvestorsObserver. SELB gets an overall rating of 72. That means it scores higher than 72 percent of stocks. Selecta Biosciences Inc gets a 83 rank in the Biotechnology industry. Biotechnology is number 15 out of 148 industries.

Overall Score - 72
SELB has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on SELB!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Selecta Biosciences Inc Stock Today?

Selecta Biosciences Inc (SELB) stock is trading at $1.72 as of 3:04 PM on Wednesday, Oct 5, a drop of -$0.03, or -1.71% from the previous closing price of $1.75. The stock has traded between $1.68 and $1.77 so far today. Volume today is less active than usual. So far 214,569 shares have traded compared to average volume of 956,805 shares. Click Here to get the full Stock Report for Selecta Biosciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App